Sanofi, Eisai Back Lilly's $20M Cialis Patent Loss Challenge
Pharmaceutical giants Sanofi and Eisai on Monday threw their support behind Eli Lilly, urging the U.S. Supreme Court to review a lower court's $20 million ruling finding that Lilly infringed a...To view the full article, register now.
Already a subscriber? Click here to view full article